Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001000858 | SCV001157933 | uncertain significance | not specified | 2018-10-15 | criteria provided, single submitter | clinical testing | The STEX c.1505G>A; p.Arg502Gln variant (rs534723946), to our knowledge, is not reported in the medical literature or gene specific databases. This variant is found in the non-Finnish European population with an allele frequency of 0.0036% (4/111,582 alleles) in the Genome Aggregation Database. The arginine at codon 502 is moderately conserved, and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. Due to limited information, the clinical significance of the p.Arg502Gln variant is uncertain at this time. |
Labcorp Genetics |
RCV002549143 | SCV003264313 | benign | Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2022-12-06 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003233919 | SCV003931546 | uncertain significance | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003233920 | SCV003931547 | uncertain significance | Amyotrophic lateral sclerosis type 4 | 2023-02-08 | criteria provided, single submitter | clinical testing |